In its current form, the proposed National Health Insurance (NHI) is by no means perfect and there remains a lot of uncertainty around funding, medical skills shortages, the role medical aids will play and how infrastructural problems, wastage and corruption in the public sector will be tackled.
“Healthcare reform challenges all of us that operate in the sector to keep and expand our place at the table. It is becoming increasingly clear, however, that NHI is here to stay, which makes it imperative for pharmaceutical companies to get involved in the debate at the highest level in order to help shape a sustainable and effective healthcare system for South Africa,” says Erik Roos, CEO of Pharma Dynamics…
Continue reading…